Stock QPT QUEST PHARMATECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Quest PharmaTech Inc.

Equities

QPT

CA74836M1068

Biotechnology & Medical Research

Delayed Toronto S.E.
Other stock markets
 11:31:09 2024-06-07 am EDT 		5-day change 1st Jan Change
0.025 CAD +25.00% Intraday chart for Quest PharmaTech Inc. +25.00% -54.55%
May. 30 Quest Pharmatech Inc. Announces the Appointment of Bradley J. Glass to the Board of Directors CI
May. 29 Quest PharmaTech Inc. Reports Earnings Results for the Full Year Ended January 31, 2024 CI

Valuation

Fiscal Period: January 2019 2020 2021 2022 2023 2024
Capitalization 1 26.78 19.25 32.76 15.14 11.84 4.228
Enterprise Value (EV) 1 23.32 19.54 32.87 15.39 12.46 4.511
P/E ratio -6.09 x -3.11 x 0.18 x -0.18 x -1.61 x -1.4 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA -2.58 x -1.43 x -30.8 x -19.5 x -15.2 x -3.44 x
EV / FCF -5.91 x 13.8 x -1.83 x -138 x -21 x -9.25 x
FCF Yield -16.9% 7.22% -54.6% -0.72% -4.76% -10.8%
Price to Book -2.61 x -1.26 x 0.19 x 0.17 x 0.14 x 0.18 x
Nbr of stocks (in thousands) 167,389 167,389 167,999 168,239 169,129 169,129
Reference price 2 0.1600 0.1150 0.1950 0.0900 0.0700 0.0250
Announcement Date 5/30/19 6/26/20 5/31/21 5/26/22 5/31/23 5/29/24
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: January 2019 2020 2021 2022 2023 2024
Net sales - - - - - -
EBITDA 1 -9.034 -13.63 -1.068 -0.7887 -0.8207 -1.313
EBIT 1 -9.042 -13.63 -1.07 -0.7906 -0.8342 -1.316
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -8.641 -13.25 190.1 -85.04 -7.332 -3.018
Net income 1 -4.393 -6.184 190.1 -85.04 -7.332 -3.018
Net margin - - - - - -
EPS 2 -0.0263 -0.0369 1.112 -0.5055 -0.0435 -0.0178
Free Cash Flow 1 -3.946 1.411 -17.96 -0.1112 -0.5933 -0.4877
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 5/30/19 6/26/20 5/31/21 5/26/22 5/31/23 5/29/24
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: January 2019 2020 2021 2022 2023 2024
Net Debt 1 - 0.29 0.11 0.25 0.63 0.28
Net Cash position 1 3.46 - - - - -
Leverage (Debt/EBITDA) - -0.021 x -0.0986 x -0.3165 x -0.7619 x -0.2156 x
Free Cash Flow 1 -3.95 1.41 -18 -0.11 -0.59 -0.49
ROE (net income / shareholders' equity) 1,152% 127% 239% -64% -8.44% -5.67%
ROA (Net income/ Total Assets) -60.8% -166% -0.74% -0.37% -0.59% -1.51%
Assets 1 7.227 3.723 -25,581 22,946 1,233 199.7
Book Value Per Share 2 -0.0600 -0.0900 1.040 0.5400 0.4900 0.1400
Cash Flow per Share 2 0 0.0100 0 0 0 0
Capex 1 0 - - - - -
Capex / Sales - - - - - -
Announcement Date 5/30/19 6/26/20 5/31/21 5/26/22 5/31/23 5/29/24
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
QUEST PHARMATECH INC. Stock Quest PharmaTech Inc.
-54.55% 2.47M
MODERNA, INC. Stock Moderna, Inc.
+53.60% 59.28B
LONZA GROUP AG Stock Lonza Group AG
+41.42% 40.94B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-5.33% 40.17B
CELLTRION, INC. Stock Celltrion, Inc.
-5.16% 28.69B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+12.59% 26.63B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-20.83% 18.89B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+30.40% 12.46B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+0.51% 12.42B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+26.60% 12.26B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. QPT Stock
  4. Financials Quest PharmaTech Inc.